These results suggest that the downregulation of PD-L1 through acetylation mutation in ovarian cancer cells can cause DNA damage, which in turn can activate STING and its downstream genes, such as p21 and caspase-3, to mediate cell cycle arrest and apoptosis. The gene discussed is STING1; the disease is ovarian carcinoma.